|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00227084 |
|
Date of registration:
|
23/09/2005 |
|
Primary sponsor: |
|
|
Public title:
|
Effect of Arista Powder on Bleeding in Reductive Mammary Surgery
|
|
Scientific title:
|
Effect of Arista AH-Haemostatic Powder in Plastic Surgery. A Prospective, Consecutive Randomized Study in 30 Women Undergoing Reduction of Both Mamma |
|
Date of first enrolment:
|
September 2005 |
|
Target sample size:
|
30 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00227084 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment
|
|
|
Countries of recruitment
|
|
Norway
| | | | | | | |
|
Contacts
|
|
Name:
|
Christian Askenberg, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Ullevaal University Hospital |
|
|
Name:
|
Petter A Steen, MD,PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University of Oslo |
| |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- All women for mammary hypertrophy day surgery. No exclusions in this group.
Age minimum:
N/A
Age maximum:
N/A
Gender:
Female
|
|
Health Condition(s) or Problem(s) studied
|
|
Mammaplasty
|
|
Intervention(s)
|
|
Drug: Arista AH hemostasis powder
|
|
Primary Outcome(s)
|
|
amount of bleeding on drain
|
|
duration of surgery
|
|
Secondary ID(s)
|
|
1.2005.419
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|